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Carbonic anhydrase IX (CA IX) is a tumor-associated, hypoxia-induced enzyme involved in pH regu-
lation and cell adhesion. Its catalytically active ectodomain (ECD) is linked to a transmembrane
region and a short intracellular (IC) tail. Removal of the IC tail causes intracellular localization of
CA IX. Mutations of basic amino acids within IC do not perturb the membrane position, but reduce
shedding of the CA IX ectodomain as well as CA IX-mediated cell dissociation. Moreover, they abol-
ish the CA IX capacity to acidify extracellular pH (pHe) and bind CA IX-selective sulfonamide inhib-
itor in hypoxia. These ﬁndings provide the ﬁrst evidence for the critical contribution of the IC tail to
the proper functioning of CA IX.
Structured summary:
MINT-7293982: E-cadherin (uniprotkb:Q95LE0) and CA IX (genbank_protein_gi:223556027) colocalize
(MI:0403) by ﬂuorescence microscopy (MI:0416)
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction mor physiology, CA IX is intensively studied as an intrinsic markerCarbonic anhydrase IX (CA IX) is an integral plasma membrane
protein regulated by hypoxia and expressed in a broad spectrum of
human tumors, while being absent frommajority of normal tissues
[1]. It is one of the most efﬁcient members of a carbonic anhydras-
es (CAs), a family of zinc metalloenzymes that catalyze a reversible
conversion of carbon dioxide to bicarbonate ion and a proton [2].
CAs are usually expressed in well differentiated metabolically ac-
tive cells and tissues, where they play important physiological
roles in facilitating ion transport and maintaining pH homeostasis
[3]. The tumor-associated CA IX isoenzyme actively contributes to
acidiﬁcation of extracellular pH (pHe) and neutralization of intra-
cellular pH in cells exposed to hypoxia and/or acidosis and thereby
functions as a survival factor protecting tumor cells from acidic
pericellular microenvironment [4–7]. Based on tumor-related, hy-
poxia-induced expression and direct functional involvement in tu-chemical Societies. Published by E
ECD, ectodomain; FITC-CAI,
MAb, monoclonal antibody;
e
).of hypoxia, prognostic indicator and therapy target for selective
inhibitors of catalytic activity and speciﬁc monoclonal antibodies
[1,8].
The CA IX protein consists of a large extracellular part, contain-
ing a unique N-terminal proteoglycan-like region (PG) and a car-
bonic anhydrase domain (CA) which is highly active for the
catalytic function of the enzyme, i.e. CO2 hydration. This extracel-
lular domain is anchored in the plasmamembrane via a single-pass
transmembrane region (TM), which is C-terminally extended into a
short intracellular tail (IC) [9,10]. The catalytic CA domain is clearly
required for the CA IX-mediated pH regulation in hypoxia [4] and
the PG domain appears to be involved in cell adhesion-related
function of CA IX [11]. However, the role of the IC tail has remained
unexplored. Here we demonstrate for the ﬁrst time that this short
C-terminal portion is essential for proper functioning of CA IX.
2. Materials and methods
2.1. Cell culture
MDCK cells and their transfected derivatives were grown in
DMEM with 10% FCS and buffered with 22.3 mM bicarbonate [4].lsevier B.V. All rights reserved.
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ium 24 h before the transfer to hypoxia (2% O2, 2% H2, 5% CO2,
91% N2) in an anaerobic Workstation (Ruskin Technologies). Paral-
lel normoxic dishes were incubated in air with 5% CO2. At the end
of each experiment, pH of the culture medium was immediately
measured, the medium was harvested for the determination of
the lactic acid content with the Lactate Reagent kit (Trinity Bio-
tech), the cells were counted and processed either for immunoﬂu-
orescence or extracted for immunoblotting.
2.2. Sulfonamide treatment of cells
The ﬂuorescent CAI sulfonamide (FITC-CAI) was obtained from
homosulfanilamide and ﬂuorescein isothiocyanate as described
[4], dissolved in PBS at 100 mM concentration and diluted in a cul-
ture medium just before the addition to cells. The cells were incu-
bated for 48 h in hypoxia and normoxia, respectively, and the
binding of the FITC-CAI to living cells was viewed by a Nikon
E400 epiﬂuorescence microscope.
2.3. Cloning of CA IX mutants and transfection
In vitro mutagenesis of IC tail was performed by PCR using
the pSG5C-CA IX plasmid [9] and following primers: ICMUT4S
ggaaggcagcacggagggggaaccggagggggt, ICMUT4A accccctccggttccc
cctccgtgctgccttcc, ICMUT5S gtgcagatgggagggcagcacgga, ICMUT5A
tccgtgctgccctcccatctgcac. MDCK cell lines constitutively express-
ing CA IX protein or its mutants were obtained by co-transfec-
tion of pSG5C-CA IX, pSG5C-mut3R1K and pSG5C-mut4R1K
plasmids with pSV2neo in a 10:1 ratio using a GenePorter II
transfection kit (Genlantis). Transfected cells were selected in
500 lg/ml G418, cloned, tested for CA IX and expanded. At
least three clonal cell lines expressing each CA IX form were
analyzed to eliminate the effect of clonal variation. The cells
cotransfected with empty pSG5C and pSV2 neo were used as
mock controls.
2.4. Immunoﬂuorescence and confocal microscopy
Cells grown on glass coverslips were ﬁxed in ice-cold metha-
nol at 20 C for 10 min and stained with CA IX-speciﬁc FITC-la-
beled monoclonal antibody (MAb) M75 directed to the PG
domain [12]. To colocalize CA IX with E-cadherin, the ﬁxed cells
were ﬁrst incubated with anti-E-cadherin MAb (1:500, BD
Transduction Laboratories) and anti-mouse antibody conjugated
with Alexa Fluor 594 (1:2000, Invitrogen), and then with FITC-
conjugated M75. Nuclei were stained with DAPI (1:36 000,
Sigma). Samples were analyzed by Zeiss LSM 510 Meta confocal
microscope, scanned in multitrack mode and deconvoluted by
Huygens software (Scientiﬁc Volume Imaging). DIC mutant was
colocalized with endoplasmic reticulum using protein disulﬁde
isomerase (PDI)-speciﬁc goat polyclonal antibody (1:50,
Santa Cruz) and with Golgi apparatus using Golgin-97 mouse
MAb (1:100, Invitrogen) followed by Alexa Fluor 594 and
633-conjugated secondary antibodies (Invitrogen). Consequent
staining with FITC-M75 and analysis were performed as
above.
2.5. Immunoblotting and ELISA
The cells were rinsed with PBS and extracted in RIPA buffer for
30 min on ice. Protein concentrations were quantiﬁed using the
BCA kit (Pierce). The proteins (50 lg/lane) were resolved in 10%
SDS–PAGE under reducing and non-reducing conditions, respec-
tively, transferred to PVDF membrane and CA IX was detected with
the M75 as described [4].CA IX ectodomain shed to culture medium was determined by
sandwich ELISA using capture V/10 MAb and detector M75 MAbs
as described earlier [13].
2.6. Cell dissociation assay
MDCK cells were grown for 3 days to form a highly dense mono-
layer. After washing twice with PBS containing 2 mM CaCl2 and
2 mM MgCl2, the cells were detached using a cell scraper, passed
30 times through the Pasteur pipete and counted using Coulter
Counter (Beckmann Coulter). The extent of dissociation was ex-
pressed as a ratio of Np/Nc, i.e. number of disrupted particles per
total number of cells obtained by counting the cells from the par-
allel monolayer fully dissociated in PBS. Resulting values of disso-
ciation were compared by t test and p < 0.05 was considered
signiﬁcant.3. Results
3.1. Removal of IC tail leads to loss of plasma membrane localization of
CA IX
The domain-deletion strategy employed in our earlier experi-
ments was helpful in elucidating the functional signiﬁcance of
the extracellular portion of CA IX. Therefore, we decided to clar-
ify the role of IC tail using similar approach. MDCK cells were
transfected with pSG5C-DIC plasmid encoding the CA IX protein
lacking 24 amino acids from the C-terminus. However, confocal
microscopic analysis revealed that this C-terminally truncated
protein is not present at the cell surface, but is localized intracel-
lularly, overlapping with the marker of endoplasmic reticulum
(Fig. 1A–C). Cell surface fraction of DIC determined by ELISA rep-
resented less than 5% of the total cellular content of DIC, in con-
trast to wt CA IX that was almost completely localized in the
plasma membrane (Fig. 1D). Aberrant localization of DIC indi-
cated that TM region preserved in this deletion variant is not
sufﬁcient for the correct transport and/or anchorage of CA IX
in the plasma membrane and that the intracellular tail of CA
IX is needed for these processes. This idea strongly implicated
that IC tail might be involved in intracellular protein–protein
interactions that drive CA IX transport and stabilize its cell sur-
face localization.
3.2. Mutations of basic amino acids in IC tail perturb neither
localization nor oligomerization of CA IX
Intracellular position of DIC precluded further functional anal-
yses of truncated CA IX, since both cell adhesion- and pH regula-
tion-related roles require presence of CA IX at the cell surface. We
thus performed a hydrophobic cluster analysis (HCA) of the IC se-
quence to identify amino acids that could mediate binding of CA
IX with intracellular proteins. HCA revealed that the basic amino
acids, namely arginines and lysine localized just next to hydro-
phobic TM region, form a distinct cluster (Fig. 2A). Since diverse
proteomic and bioinformatic approaches propose that basic, pos-
itively charged amino acids are exposed at the protein–protein
interfaces, we assumed that these residues might be involved in
CA IX interaction(s) with other molecules. On this basis, we gen-
erated two variants of CA IX, the ﬁrst one with three argi-
nine? glycine and one lysine? glycine substitutions (named
mut3R1K? G) and the second one with four arginine? glycine
and one lysine? glycine substitutions (named mut4R1K? G),
see Fig. 2B. Both mutants were correctly transported to plasma
membrane and were also able to form oligomers similar to wt
CA IX (Fig. 2C and D).
Fig. 1. Aberrant subcellular localization of DIC mutant of CA IX demonstrated by confocal microscopy (A–C) and ELISA (B). (A) Wild-type CA IX was localized at the plasma
membrane and overlapped with E-cadherin, as detected by FITC-conjugated monoclonal antibody M75 speciﬁc for PG domain of CA IX and with anti-E-cadherin MAb
followed by Alexa Fluor 594-conjugated anti-mouse IgG (B) In contrast, DIC mutant exhibited intracellular localization. (C) It colocalized predominantly with endoplasmic
reticulum (ER) detected with PDI-speciﬁc goat polyclonal antibody and Alexa Fluor 594-conjugated anti-goat IgG and partially also with Golgi apparatus (GA) detected with
Golgin-97 MAb and Alexa Fluor 633-anti-mouse IgG. (D) In ELISA with M75 MAb, total amount of CA IX antigen was determined in ﬁxed cells and fraction of cell surface
antigen was detected on living cells. DIC mutant was virtually absent from plasma membrane.
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of CA IX
Correct localization and oligomerization of IC mutants allowed
us to perform further analyses of their properties. We ﬁrst looked
at the rate of metalloproteinase-mediated ectodomain shedding
described before for CA IX [13]. Interestingly, both IC mutants
exhibited signiﬁcantly reduced constitutive as well as PMA-in-
duced shedding, when compared to wild type CA IX (Fig. 3A). This
could suggest that the region(s) involved in binding and/or cleav-
age by metalloproteinase was not efﬁciently recognized possibly
due mutation-related structural changes. Moreover, the mutant
cDNAs-transfected MDCK cells also showed decreased dissociation
indicating that the mutations perturbed cell-deadhesion capacity
of CA IX [14]. Noteworthy, the CA IX variant containing 3R? G
mutations was more disabled than the variant with 4R? G
mutations.
3.4. Mutations in IC tail abolish CA IX-mediated extracellular
acidiﬁcation and inhibitor binding
Via extracellular catalytic domain CA IX signiﬁcantly contrib-
utes to pH regulation of hypoxic and acidic cells and thereby plays
a role in tumor biology [4–7]. We wanted to ﬁnd out whether
mutations in IC tail could affect this salient feature of CA IX. Mea-surements of extracellular pH of MDCK cells expressing mutated
variants of IC revealed that both mutants lost the capability to
acidify extracellular medium under hypoxia (Fig. 4A). In accord
with disabled pH regulatory function, both IC mutants were also
unable to bind and accumulate FITC-conjugated CA inhibitor,
although a faint ﬂuorescence could be observed in cells transfected
with mut4R1K? G variant (Fig. 4B). These results clearly showed
that integrity of IC tail is crucial for post-translational processing
and biological activities of CA IX.
4. Discussion
Recent functional studies of CA IX focus predominantly on its
extracellular portion that contains two distinct domains, the PG-
like domain at the very N-terminus and the catalytic CA domain lo-
cated above the plasma membrane. Particularly, the CA domain at-
tracts a lot of attention due to its important role in pH regulation
that is vital for adaptation of tumor cells to physiological stress
from hypoxia and acidosis. The CA domain faces the extracellular
space and is capable to efﬁciently catalyze hydration of pericellular
carbon dioxide. This facilitates CO2 excretion coupled with extra-
cellular acidiﬁcation (through production of extracellular protons)
and intracellular neutralization (through production of bicarbon-
ate ions for inﬂux by bicarbonate transporters) [15]. Also the PG
domain, which is not present in any other carbonic anhydrase, is
Fig. 2. Amino acid sequence analysis, localization and oligomerization of IC tail
mutants of CA IX. (A) HCA plot derived from TM and IC domains of CA IX shows
duplicated set of amino acids written on a cylinder, which is cut parallel to its axis.
The transmembrane hydrophobic amino acids are enclosed in polygonal shapes
corresponding to alpha helices, clusters of juxtamembrane basic amino acids are
depicted by red color. (B) Schematic illustration of the structural domains of CA IX
with IC tail mutations speciﬁed below the scheme. (C) Immunoﬂuorescence
analysis with FITC-conjugated M75 MAb shows plasma membrane localization of
both IC mutants. (D) Immunoblotting analysis of IC mutants separated under non-
reducing conditions (without 2b-mercaptoethanol, ME) and reducing conditions
(+ME) demonstrates their correct molecular weight and oligomerization. Blotted
proteins were visualized with M75 MAb followed by peroxidase-conjugated anti-
mouse IgG.
Fig. 3. Ectodomain shedding and dissociation capacity of IC mutants. (A) Sandwich
ELISA assessment of CA IX ectodomain produced to culture medium of MDCK cells
transfected with wt CA IX and IC mutants under basal conditions and upon
activation with PMA. Shed CA IX was determined with combination of CA domain-
speciﬁc V/10 MAb as a capture and PG domain-speciﬁc M75 MAb as detector. Total
cellular content of the proteins was determined in cell extracts. IC mutants
exhibited reduced shedding under both conditions. (B) Dissociation assay showed
diminished perturbation of intercellular contacts of cells transfected with IC
mutants, as evident from reduced number of particles (Np) obtained by monolayer
disruption, when calculated to total cell number (Nc).
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well as to its capacity to improve the CA IX catalytic activity under
acidic pH.
Up till now, contribution of a short intracellular tail to CA IX
function has remained unclear. The only study related to IC domain
of CA IX describes the EGF-mediated Y449 phosphorylation and sig-
nal transduction leading to Akt activation [16].
However, the literature offers many examples of transmem-
brane molecules, cytoplasmic domains of which mediate not only
outside-in signaling, but also inside-out effects on localization,post-translational processing and functional ‘‘ﬁtness” of extracellu-
lar domains [17–21]. CA IX clearly belongs to this category of
transmembrane proteins, because removal of its IC domain chan-
ged its subcellular localization, so that CA IX was almost com-
pletely lost from the cell surface. This happened despite the
transmembrane region was preserved, indicating that IC domain
is instructive for the correct localization of CA IX. As these pro-
cesses usually include interactions with other proteins, it was the
ﬁrst hint suggesting that removal of IC might disrupt cross-talk be-
tween CA IX and its partners.
Deeper insight into the sequence and clustering of IC amino
acids revealed presence of ﬁve basic residues in 436RRXXRRXXK444
motif that formed a distinct cluster on HCA plot next to the trans-
membrane helix. Interestingly, these juxtamembrane amino acids
are well conserved also in mouse, dog, and rat CA IX orthologs as
well as in cytoplasmic tails of CA XII and CA XIV isoenzymes
(Fig. 5). Such basic and positively charged amino acids are usually
located at protein–protein interfaces and numerous bioinformatic
as well as experimental studies propose their role in mediating
protein–protein interactions [19,22–24]. Therefore, we produced
two mutants with either 4 or 5 substitutions of arginines and ly-
sine to glycine. Noteworthy, these changes affected neither cell
surface localization nor oligomerization of CA IX and thus the juxt-
amembrane basic amino acids do not seem to be involved in inter-
actions governing cell surface position of CA IX and formation of
oligomers.
However, both mutants showed a signiﬁcantly reduced basal as
well as PMA-activated shedding of CA IX ectodomain (ECD). One
possible mechanism behind this effect could involve inside-out
modiﬁcation of ectodomain folding and decreased binding of
metalloproteinase(s) responsible for the CA IX ECD cleavage. For
example TNFa-converting enzyme (TACE), involved in activated
shedding of CA IX ECD [13], has no simple linear consensus se-
quence and mediates proteolysis via a distant epitope [25]. It is
thus well possible that inside-out induced misfolding of this epi-
tope could diminish recognition of CA IX or accessibility of its
extracellular cleavage site by TACE, resulting in less effective shed-
ding. Similar inside-out effects could underlie decreased dissocia-
tion of MDCK cells expressing the mutated CA IX variants.
Finally, IC mutations severely affected the capacity of CA IX to
acidify extracellular pH and bind CA IX-selective FITC-conjugated
inhibitor in hypoxia, thereby disabling the most important extra-
cellular function of CA IX. Also this effect might be explained by in-
side-out induced allosteric change, similarly as recently described
for EGFR [18]. The change could potentially disrupt a communica-
Fig. 4. Effect of IC mutations on CA IX-mediated extracellular acidiﬁcation and binding of inhibitor. (A) Extracellular pH was measured in transfected MDCK cells incubated
for 48 h in normoxia and hypoxia, respectively. The graph shows differences between pH values (DpH) obtained with CA IX-transfected and mock-transfected cells. Both IC
mutants were clearly unable to acidify extracellular pH. (B) Differences in extracellular lactate concentrations among the transfectants. (C) Accumulation of FITC-CAI occurred
in hypoxic cells expressing the wild-type CA IX, whereas it was diminished in all other hypoxic and normoxic cultures.
Fig. 5. Alignment of IC domains of human CA IX with its orthologs, as well as with
CA XII and CA XIV. Conserved basic amino acids are shaded.
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which is meaningful for locally concentrated production and con-
sequent inﬂux of bicarbonate ions, and proper pH regulation
[15,26]. Indeed, decreased inhibitor binding does not deny this
possibility.
In addition, it is still possible that the mutations of juxtamem-
brane basic amino acids directly affect binding of cytoplasmic pro-
tein(s) to IC domain of CA IX due to disruption of the positively
charged interface and that loss of intracellular partner(s) is the
main reason for the proposed allosteric changes in extracellular
portion of CA IX. Alternatively, the mutations might perturb signal-
ing through CA IX to Akt (similarly as observed with mutation of
Y449) and thereby affect extracellular functions of CA IX, including
its capacity to acidify extracellular pH. Interestingly, the juxta-
membrane basic amino acid motif subjected to mutations encom-
passes T443 residue that is another putative phosphorylation site
potentially involved in the phenomena described here. In fact, pos-
sible relationship of the mutated basic amino acids to functional
status and to signal transduction elicited by CA IX would represent
plausible explanation for our present observations and therefore
clearly requires further investigations.
However, even without full understanding of the mechanism by
which mutations of basic amino acids in the sub-membrane region
affect processing and activities of CA IX, we can conclude that this
study brings a novel view on molecular prerequisites of proper CA
IX functioning. Moreover, the ﬁndings described here offer a newstrategy for inactivation of extracellular functions of CA IX through
targeting its IC tail.
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